Related references
Note: Only part of the references are listed.Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER plus Advanced Breast Cancer
Ben O'Leary et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
Estelle Bourbon et al.
PHARMACEUTICALS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen et al.
CLINICAL CANCER RESEARCH (2021)
The mutational landscape of human somatic and germline cells
Luiza Moore et al.
NATURE (2021)
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
Xinghao Ai et al.
CLINICAL CANCER RESEARCH (2021)
Towards systematic nomenclature for cell-free DNA
Abel J. Bronkhorst et al.
HUMAN GENETICS (2021)
The pre-analytical phase of the liquid biopsy
Francesca Salvianti et al.
NEW BIOTECHNOLOGY (2020)
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre) analytical Work Flows
Rita Lampignano et al.
CLINICAL CHEMISTRY (2020)
Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations
Abel Jacobus Bronkhorst et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
Pre-analytical issues in liquid biopsy-where do we stand?
Michael Fleischhacker et al.
JOURNAL OF LABORATORY MEDICINE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
Richard S. Finn et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Jonathan C. M. Wan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Challenges and achievements of liquid biopsy technologies employed in early breast cancer
Alfonso Alba-Bernal et al.
EBIOMEDICINE (2020)
Assessment of Molecular Remission in Oligometastatic Esophageal Cancer With a Personalized Circulating Tumor DNA Assay
David J. Einstein et al.
JCO PRECISION ONCOLOGY (2020)
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Romain Meddeb et al.
CLINICAL CHEMISTRY (2019)
Cell-free tumour DNA testing for early detection of cancer - a potential future tool
G. Barbany et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U. Pastorino et al.
ANNALS OF ONCOLOGY (2019)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
Allen Lee Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA
Nathan Wan et al.
BMC CANCER (2019)
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi et al.
NATURE MEDICINE (2019)
High-accuracy liquid biopsies
Beatriz Bellosillo et al.
NATURE MEDICINE (2019)
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients
Norikazu Masuda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
Mathilde Postel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications
Anna-Lena Volckmar et al.
GENES CHROMOSOMES & CANCER (2018)
Abstract OT3-02-01: Development of cell-free nucleic acid-based tests for early detection of breast cancer: The STRIVE study
MC Liu et al.
CANCER RESEARCH (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu et al.
CLINICAL CANCER RESEARCH (2018)
Genome-wide sequencing for early stage lung cancer detection from plasma cell-free DNA (cfDNA): The Circulating Cancer Genome Atlas (CCGA) study.
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
Shang-Gin Wu et al.
MOLECULAR CANCER (2018)
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
Zhijie Wang et al.
LANCET RESPIRATORY MEDICINE (2018)
Development of plasma cell-free DNA (cfDNA) assays for early cancer detection: first insights from the Circulating Cell-Free Genome Atlas Study (CCGA)
Alexander A. Aravanis et al.
CANCER RESEARCH (2018)
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
Ben O'Leary et al.
CANCER DISCOVERY (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literature
R. M. Trigg et al.
HELIYON (2018)
Gefitinib for advanced non-small cell lung cancer
Esther H. A. Sim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature
Sonia Khier et al.
FUTURE SCIENCE OA (2018)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
Nancy K. Gillis et al.
LANCET ONCOLOGY (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Ian A. Cree et al.
BMC CANCER (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing
Takehiro Yanagawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2
Mary Ellen Moynahan et al.
BRITISH JOURNAL OF CANCER (2017)
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
Wang Yao et al.
GENE (2016)
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli et al.
LANCET ONCOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty et al.
JAMA ONCOLOGY (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel et al.
CLINICAL CANCER RESEARCH (2015)
ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Somatic mutation in cancer and normal cells
Inigo Martincorena et al.
SCIENCE (2015)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors
Cynthia X. Ma et al.
STEROIDS (2011)
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening Five-Year Results of a Prospective Study
Gabriella Sozzi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Expression of the K303R Estrogen Receptor-α Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
Ines Barone et al.
CANCER RESEARCH (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence:: A prospective study
Emmanuelle Gormally et al.
CANCER RESEARCH (2006)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
